Dr. Papakostas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit St
S50 4 Massachusetts General Hospital
Boston, MA 02114Phone+1 617-726-6697- Is this information wrong?
Education & Training
- Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1999 - 2002
- Steward Carney HospitalInternship, Internal Medicine, 1998 - 1999
- New York University School of MedicineClass of 1998
Certifications & Licensure
- MA State Medical License 2002 - 2024
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression Start of enrollment: 2004 May 01
- A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD) Start of enrollment: 2006 Nov 01
- A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder Start of enrollment: 2008 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial.George I Papakostas, Madhukar H Trivedi, Richard C Shelton, Dan V Iosifescu, Michael E Thase, Manish K Jha, Sanjay J Mathew, Charles DeBattista, Mehmet E Dokucu, Olga ...> ;Molecular Psychiatry. 2024 Mar 7
- 2 citationsPharmacotherapy: Ketamine and Esketamine.Anna Feeney, George I Papakostas> ;The Psychiatric Clinics of North America. 2023 Jun 1
- 3 citationsRapidity of Symptom Improvement With Intranasal Esketamine for Major Depressive Disorder: A Systematic Review and Meta-Analysis.Rebecca S Hock, Anna Feeney, Nadia Iovieno, James W Murrough, Sanjay J Mathew, Dan V Iosifescu, Maurizio Fava, Manish K Jha, George I Papakostas> ;The Journal of Clinical Psychiatry. 2022 Dec 12
- Join now to see all
Journal Articles
- Research Paper Tachyphylaxis in Major Depressive Disorder: A Review of the Current State of ResearchGustavo Kinrys, Andrew A Nierenberg, George I Papakostas, David Mischoulon, Maurizio Fava, Marlene P Freeman, ScienceDirect
- Double-Blind, Placebo-Controlled, Dose-Ranging Trial of Intravenous Ketamine as Adjunctive Therapy in Treatment-Resistant Depression (TRD)Sanjay J Mathew, Madhukar H Trivedi, Lee C Chang, Dan V Iosifescu, Manish K Jha, Maurizio Fava, Marlene P Freeman, Cristina Cusin, James Murrough, George I Papakostas,..., Nature
Press Mentions
- 4 Serotonin Supplements to Treat Depression, Anxiety, & Insomnia YourselfJune 5th, 2019
- Allergan’s Phase III Botox Trial for Depression Pushed to H2 2019December 10th, 2018
- Major Depression ZiprasidoneOctober 6th, 2017
- Join now to see all
Grant Support
- 1/2-Ziprasidone Augmentation Of Ssris For Treatment-Resistant Depression (TRD)National Institute Of Mental Health2008–2012
- S-Adenosyl Methionine(Same)Augmentation Of Ssris In MDDNational Institute Of Mental Health2004–2008
Hospital Affiliations
- Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: